Evidence map›Paper›PMID 32819335›Full record

ArticleBMC public health2020

Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.

Carin Ahouada, Souleymane Diabaté, Myrto Mondor, Septime Hessou, Fernand A Guédou, Luc Béhanzin, Georges Batona, Ndeye Ndiagna Gning, D Marcel Zannou, Michel Alary

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Carin AhouadaHopital de Zone Allada, Allada, Benin.
Souleymane DiabatéCentre de recherche du CHU de Québec, Université Laval, Québec, Québec, Canada.
Myrto MondorCentre de recherche du CHU de Québec, Université Laval, Québec, Québec, Canada.
Septime HessouCentre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED/UAC), Abomey-Calavi, Bénin.
Fernand A GuédouDispensaire des IST, Centre de Santé Cotonou I, Cotonou, Bénin.
Luc BéhanzinDispensaire des IST, Centre de Santé Cotonou I, Cotonou, Bénin.
Georges BatonaDispensaire des IST, Centre de Santé Cotonou I, Cotonou, Bénin.
Ndeye Ndiagna GningCentre de recherche du CHU de Québec, Université Laval, Québec, Québec, Canada.
D Marcel ZannouCentre National Hospitalier et Universitaire Hubert Koutoukou Maga de Cotonou, Cotonou, Benin.
Michel AlaryCentre de recherche du CHU de Québec, Université Laval, Québec, Québec, Canada. michel.alary@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0002-0246-4429
Centre hospitalier de l'Université Laval · CACentre National Hospitalier et Universitaire Hubert Koutoukou MAGA · BJHôpital du Saint-Sacrement · CAUniversité Alassane Ouattara · CIUniversité de Parakou · BJ

Funding

CIHR FDN-143218
6 · The paper itself

Abstract

backgroundIn Benin, men who have sex with men (MSM) do not always use condoms during anal sex. Pre-exposure prophylaxis (PrEP) using Truvada® (tenofovir disoproxil fumarate / emtricitabine) may be a complementary HIV prevention measure for MSM. This study aimed at identifying the potential facilitators and barriers to the use of PrEP.

methodsThis was a cross-sectional study conducted in 2018 among male-born MSM aged 18 years or older who reported being HIV-negative or unaware of their HIV status. The participants were recruited by the RDS technique (respondent driven sampling) in six cities of Benin. Logistic regression analyses, adapted to RDS statistical requirements, were performed to identify the factors associated with PrEP acceptability.

resultsMean age of the 400 MSM recruited was 26.2 ± 5.0 years. PrEP was known by 50.7% of respondents. The intention to use PrEP was expressed by 90% of MSM. If PrEP effectiveness were 90% or more, 87.8% of the respondents thought they would decrease condom use. In multivariate analysis, the facilitators associated with PrEP acceptability were: not having to pay for PrEP (odds ratio (OR) = 2.39, 95% CI: 1.50-4.46) and its accessibility within MSM networks (OR = 9.82, 95% CI: 3.50-27.52). Only one barrier was significant: the concern that taking PrEP be perceived as marker of adopting HIV risky behaviors (OR = 0.11, 95% CI: 0.04-0.30).

conclusionIn Benin, not all MSM know about PrEP. But once well informed, the majority seems willing to use it if made available. The free availability of the drug and its accessibility in the MSM networks are important facilitators. The possibility of decrease in condom use should not be a barrier to the prescription of PrEP if made available.

Indexed as

Homosexuality, MalePatient Acceptance of Health CareAdolescentAdultAnti-HIV AgentsBeninCitiesCondomsCross-Sectional StudiesEmtricitabineHealth Services AccessibilityHIV InfectionsHumansLogistic ModelsMaleMiddle AgedAnti-HIV AgentsEmtricitabineTenofovirAcceptabilityBeninHIVMSMPrEP

Identifiers

PMID32819335
PMCPMC7441559
OpenAlexW3081043282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.